Clinical Trial Update: Prophylaxis Regimen for Hemophilia A Patients [Phase 4]

View source ↗

Summary

Bayer reports completed Phase 4 results for a prophylaxis regimen in patients with Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Bayer | Conditions: Hemophilia A, Prophylaxis of Bleeding | Phase 4 | Status: COMPLETED | Results posted: 2025-11-12